| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BMRN | Common Stock | Award | $21.3K | +341 | +0.11% | $62.41 | 304K | Apr 30, 2021 | Direct | F1 |
| transaction | BMRN | Common Stock | Options Exercise | $662K | +25K | +8.23% | $26.49 | 329K | May 6, 2021 | Direct | F2 |
| transaction | BMRN | Common Stock | Sale | -$1.16M | -14.8K | -4.51% | $78.01 | 314K | May 6, 2021 | Direct | F2, F3 |
| transaction | BMRN | Common Stock | Sale | -$801K | -10.2K | -3.24% | $78.69 | 304K | May 6, 2021 | Direct | F2, F4 |
| transaction | BMRN | Common Stock | Options Exercise | $662K | +25K | +8.23% | $26.49 | 329K | May 7, 2021 | Direct | F2 |
| transaction | BMRN | Common Stock | Sale | -$1.21M | -15.6K | -4.73% | $77.60 | 313K | May 7, 2021 | Direct | F2, F5 |
| transaction | BMRN | Common Stock | Sale | -$482K | -6.12K | -1.95% | $78.77 | 307K | May 7, 2021 | Direct | F2, F6 |
| transaction | BMRN | Common Stock | Sale | -$264K | -3.33K | -1.08% | $79.39 | 304K | May 7, 2021 | Direct | F2, F7, F8 |
| holding | BMRN | Common Stock | 248K | Apr 30, 2021 | Shares held by Jean-Jacques Bienaime Family Trust |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BMRN | Stock Option (Right to buy Common Stock) | Options Exercise | $0 | -25K | -42.73% | $0.00 | 33.5K | May 6, 2021 | Common Stock | 25K | $26.49 | Direct | F2, F9 |
| transaction | BMRN | Stock Option (Right to buy Common Stock) | Options Exercise | $0 | -25K | -74.6% | $0.00 | 8.51K | May 7, 2021 | Common Stock | 25K | $26.49 | Direct | F2, F9 |
| Id | Content |
|---|---|
| F1 | Represents shares acquired by the reporting person on April 30, 2021, pursuant to the issuer's Employee Stock Purchase Plan. |
| F2 | Trade made pursuant to a 10b5-1 plan executed on December 3, 2020, as amended on March 29, 2021. |
| F3 | The price in column 4 is the weighted average price. The price actually received ranged from $77.375 to $78.37. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price. |
| F4 | The price in column 4 is the weighted average price. The price actually received ranged from $78.38 to $78.99. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price. |
| F5 | The price in column 4 is the weighted average price. The price actually received ranged from $77.13 to $77.95. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price. |
| F6 | The price in column 4 is the weighted average price. The price actually received ranged from $78.15 to $79.14. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price. |
| F7 | The sale reported in this Form 4 was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, to the extent of 100 shares, with the reporting person's purchase of shares at a price of $77.9400 on March 4, 2021. The reporting person has agreed to pay to the Issuer the full amount of the profit realized by the reporting person in connection with the short-swing transaction, less transaction costs. |
| F8 | The price in column 4 is the weighted average price. The price actually received ranged from $79.15 to $79.75. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price. |
| F9 | Reflects the number of options outstanding after the transactions from this specific stock option grant. |